ARS Pharmaceuticals outlines sales force expansion and digital strategy for neffy growth while maintaining SG&A in 2026

ARS Pharmaceuticals has detailed its plans for expanding its sales force and implementing a digital strategy to drive the growth of its product Neffy, while simultaneously aiming to maintain its selling, general, and administrative expenses in 2026.